Showing results (941-950 of 967) with videos related to

Sort By:
Pageof 97
Science Translational Medicine|March 4, 2016
Therapeutic targeting of oxygen-sensing prolyl hydroxylases abrogates ATF4-dependent neuronal death and improves outcomes after brain hemorrhage in several rodent modelsSaravanan S Karuppagounder, Ishraq Alim, Soah J Khim, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 15, 2018
Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorderJiao Li, Jennifer A Ruskey, Isabelle Arnulf, et al.
Nature|June 4, 2025
Integrated photonic source of Gottesman-Kitaev-Preskill qubitsM V Larsen, J E Bourassa, S Kocsis, et al.
Nature Communications|January 20, 2026
Community benchmarking and evaluation of human unannotated microprotein detection by mass spectrometry based proteomicsAaron Wacholder, Eric W Deutsch, Leron W Kok, et al.
Cell Reports. Medicine|March 2, 2023
A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profileGérémy Sannier, Alexandre Nicolas, Mathieu Dubé, et al.
Advances in Nutrition (Bethesda, Md.)|June 1, 2025
Contribution of Maternal Adherence to the Effect of Multiple Micronutrient Supplementation During Pregnancy: A Systematic Review and Individual Participant Data Meta-analysisEmily R Smith, Filomena Gomes, Seth Adu-Afarwuah, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Detection of human unannotated microproteins by mass spectrometry-based proteomics: a community assessmentAaron Wacholder, Eric W Deutsch, Leron W Kok, et al.
Science Advances|November 26, 2021
Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortalityElsa Brunet-Ratnasingham, Sai Priya Anand, Pierre Gantner, et al.
Journal of Medicinal Chemistry|December 27, 2011
Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitusJeffrey A Pfefferkorn, Angel Guzman-Perez, John Litchfield, et al.
Nature Communications|May 16, 2024
Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunityElsa Brunet-Ratnasingham, Sacha Morin, Haley E Randolph, et al.
Pageof 97